Abbott (ABT) CEO says nutrition business performance to remain challenged in H1 '26 and expects return to growth in H2 - conference call

Abbott (ABT) CEO says nutrition business performance to remain challenged in H1 '26 and expects return to growth in H2 - conference call.

Abbott's CEO indicates that the nutrition segment will face challenges in the first half of 2026 before a projected return to growth in the second half. This suggests that investors may need to brace for continued pressure on revenues and margins in the upcoming quarters, which could weigh on stock performance in the near term, though there is potential for recovery later in the year.